Results 121 to 130 of about 55,779 (204)

A dengue vaccine whirlwind update. [PDF]

Ther Adv Infect Dis, 2023
Kariyawasam R, Lachman M, Mansuri S, Chakrabarti S, Boggild AK.   +4 more
europepmc   +1 more source

T-Cell-Based Universal Dengue Vaccine Design for Robust Protective Response. [PDF]

Vaccines (Basel)
Sun YF, Yeo Syin Lian A, Moi ML.
europepmc   +1 more source

Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus [PDF]

, 2002
Bianchi, A.T.J., Boer, L.E.A., de, Heinen, P.P., Rijsewijk, F.A.   +3 more
core   +2 more sources

Dengue vaccine rollout in India: lessons for Pakistan's public health preparedness. [PDF]

Ann Med Surg (Lond)
Sah S, Ahsan A, Tariq R, Yadav T.
europepmc   +1 more source

The Tolerability of the Dengue Vaccine TAK-003 (Qdenga^®) in German Travelers: The Results of a Prospective Survey. [PDF]

Trop Med Infect Dis
Jelinek T, Kramm J, Wagner M, Jelinek C.
europepmc   +1 more source

Zidovudine to prevent mother-to-infant HIV transmission in developing countries: a view from Thailand. [PDF]

, 1999
Cawthorne, P, Kasi-Sedapan, S, Kumphitak, A, Lakhonphol, S, Sanaeha, S, Unchit, N, Wilson, D   +6 more
core   +1 more source

Dengue Serostatus and Dengue Vaccine Safety and Efficacy

New England Journal of Medicine, 2018
Posfay Barbe, Klara, L'Huillier, Arnaud
openaire   +5 more sources

Defining a Simplified Process in Yeast for Production of Enveloped VLP Dengue Vaccine. [PDF]

Bioengineering (Basel)
de Sá Magalhães S, Morris SA, Kusumawardani S, Wijayadikusumah AR, Nurainy N, Keshavarz-Moore E.   +5 more
europepmc   +1 more source

Dengue Vaccine Development and Deployment into Routine Immunization. [PDF]

Vaccines (Basel)
Wilder-Smith A, Cherian T, Hombach J.
europepmc   +1 more source

Immunogenicity of a Live Dengue Vaccine (TAK-003). [PDF]

J Infect Dis, 2022
de Silva A, White L.
europepmc   +1 more source